{
  "validation_status": "PASS",
  "validation_confidence": 0.98,
  "missed_drugs": [],
  "grounded_search_performed": true,
  "search_results": [
    {
      "drug_queried": "Zilovertamab Vedotin",
      "is_therapeutic_drug": true,
      "source_url": "https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zilovertamab-vedotin",
      "source_title": "Zilovertamab Vedotin - NCI Drug Dictionary",
      "evidence": "An antibody-drug conjugate (ADC) consisting of a humanized monoclonal antibody directed against the receptor tyrosine kinase-like orphan receptor 1 (ROR1) conjugated to the microtubule-disrupting agent monomethyl auristatin E (MMAE).",
      "confidence": "high"
    }
  ],
  "issues_found": [],
  "checks_performed": {
    "hallucination_detection": {
      "passed": true,
      "note": "All extracted items (Zilovertamab Vedotin, Cyclophosphamide, Doxorubicin, Prednisone, Rituximab) are valid therapeutic drugs confirmed via search and medical knowledge."
    },
    "omission_detection": {
      "passed": true,
      "note": "No other therapeutic drugs were identified in the title. 'Waveline-007' is correctly identified as a trial name and excluded."
    },
    "rule_compliance": {
      "passed": true,
      "note": "Title casing is maintained, and generic names are used correctly."
    },
    "misclassification_detection": {
      "passed": true,
      "note": "Keywords 'in combination with' and 'plus' correctly indicate a co-primary administration of all listed agents."
    }
  },
  "validation_reasoning": "1. Verified Zilovertamab Vedotin as a valid therapeutic ADC via grounded search.\n2. Confirmed Cyclophosphamide, Doxorubicin, Prednisone, and Rituximab are standard therapeutic agents (R-CHP components).\n3. Analyzed title structure: 'Zilovertamab Vedotin in combination with [regimen] plus Rituximab' indicates all are part of the primary experimental arm.\n4. Checked for omissions: 'Waveline-007' is a study identifier and correctly excluded per Rule 32.\n5. All extraction and classification rules were followed accurately."
}